0001493152-22-016081.txt : 20220607
0001493152-22-016081.hdr.sgml : 20220607
20220607161017
ACCESSION NUMBER: 0001493152-22-016081
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220607
DATE AS OF CHANGE: 20220607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cundy Kenneth C
CENTRAL INDEX KEY: 0001322959
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 221001324
MAIL ADDRESS:
STREET 1: 1455 ADAMS DRIVE, SUITE 2050
STREET 2: MENLO BUSINESS PARK
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4
1
ownership.xml
X0306
4
2022-06-01
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001322959
Cundy Kenneth C
C/O ANEBULO PHARMACEUTICALS, INC.
1415 RANCH ROAD 620 SOUTH, SUITE 201
LAKEWAY
TX
78734
0
1
0
0
Chief Scientific Officer
Option to purchase Common Stock
2.91
2022-06-01
4
A
0
350169
0
A
2022-07-01
2027-06-30
Common Stock
350169
350169
D
Mr. Cundy received a stock option to purchase shares of the Issuer's common stock pursuant to the Issuer's 2020 Stock Incentive Plan: (a) 233,446 shares will vest in equal quarterly installments from July 1, 2022 through April 1, 2026. (b) 116,723 shares will vest upon completion of certain milestone events.
/s/ Kenneth C Cundy
2022-06-07